Gisbert W. Selke

Head of Research

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Pharmacy Pharmacy professors in Germany

About

Gisbert W. Selke is the Head of Research at the AOK Research Institute (WIdO) in Germany. His research primarily focuses on biopharmaceuticals, healthcare policies, and drug prescribing trends, particularly in the context of the COVID-19 pandemic and orphan drugs. Recent publications explore the diffusion patterns of biopharmaceuticals in Europe, the impact of the pandemic on antidepressant use, and pricing strategies for cancer medicines across European healthcare systems.

Articles (15)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (9)

Ingrid Schubert

GERMANY

View details

Manuela Casula

University of Milan

ITALY

View details

ELISABETTA POLUZZI

Associate Professor of Pharmacology

University of Bologna

ITALY

View details

Hye-Young Kwon

Assistant Professor

Mokwon University

SOUTH KOREA

View details

Björn Wettermark

SWEDEN

View details

Carla Torre

Universidade de Aveiro

PORTUGAL

View details

Ingo Meyer

Head of research group

University of Cologne

GERMANY

View details

Caridad Pontes

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Fredrik Nyberg

Professor of Register Epidemiology

University of Gothenburg

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gisbert W. Selke

Research Interests

Explore related searches

About

Articles (15)

Introduction of Biopharmaceuticals in Europe: A Cross-Sectional Study of Early Diffusion Patterns and Data Availability

Impact of the COVID-19 pandemic on antidepressant use in eleven European regions: a comparative time series analysis 2018–2022

Clinical and non-clinical aspects of reimbursement policy for orphan drugs in selected European countries

Corrigendum to "Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe:

Prescribing of valproate and oral antiepileptics for women of childbearing age and during pregnancy in Germany between 2010 and 2020

Prescribing of valproate and oral antiepileptics for women of childbearing age and during pregnancy in Germany between 2010 and 2020

Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study

Comparison of drug prescribing before and during the COVID-19 pandemic: A cross-national European study

Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications

Trends and patterns in EU(7)-PIM prescribing to elderly patients in Germany

Trends and patterns in EU(7)-PIM prescribing to elderly patients in Germany

The Expiry of Humira(R) Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures

Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications

Variation in the prices of oncology medicines across Europe and the implications for the future

The Expiry of Humira<sup>®</sup> Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures

Collaborators (9)

Ingrid Schubert

Manuela Casula

ELISABETTA POLUZZI

Hye-Young Kwon

Björn Wettermark

Carla Torre

Ingo Meyer

Caridad Pontes

Fredrik Nyberg

Make your next move.